Arginine

Arginine

SCHEMBL1401438

N=C(N)NCCCC(N)C(=O)O.NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACES1PR1S1PR4S1PR5

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.59
ALPI P09923 1/20 0.59
PKM P14618 1/20 0.59
PTGS1 P23219 1/20 0.59
XIAP P98170 1/20 0.59
ANPEP P15144 1/20 0.50
RNPEP Q9H4A4 1/20 0.50
DNPEP Q9ULA0 1/20 0.50
SLC1A3 P43003 1/20 0.46
SLC1A2 P43004 1/20 0.46
SLC1A1 P43005 1/20 0.46
TPH1 P17752 2/20 0.45
MMP2 P08253 1/20 0.45
NPY4R P50391 3/20 0.44
NPY1R P25929 2/20 0.44
NPY2R P49146 2/20 0.44
NPY5R Q15761 2/20 0.44
LTA4H P09960 1/20 0.43
NOS3 P29474 2/20 0.43
NOS1 P29475 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL4260597 1.00 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Arginine SCHEMBL27641173 1.00 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Arginine SCHEMBL27074661 1.00 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Arginine SCHEMBL9482082 1.00 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Arginine SCHEMBL4795238 1.00 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Arginine SCHEMBL1537371 1.00 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Arginine SCHEMBL2776813 1.00 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Arginine SCHEMBL385198 1.00 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Arginine SCHEMBL14861498 1.00 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Arginine SCHEMBL28209520 0.99 SLC7A5 (0.58) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024124258-A2 METHODS OF PREPARING STABLE NUCLEIC ACID LIQUID FORMULATIONS UNIVERSITY OF NORTH CAROLINA AT WILMINGTON (US) 2024-06-13 WO claimed
US-20240191260-A1 METHODS OF PREPARING STABLE NUCLEIC ACID LIQUID FORMULATIONS UNIVERSITY OF NORTH CAROLINA AT WILMINGTON (US) 2024-06-13 US claimed
CN-109134371-B Fluorescence ratio probe, synthetic method thereof and application of fluorescence ratio probe in detecting intracellular lysosome formaldehyde 东北大学 2020-07-10 CN claimed
EP-3148591-B1 NANOPARTICLE DRUG CONJUGATES MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2020-03-11 EP claimed
US-20080261232-A1 Use of Precursors of Enkephalins and/or Their Fragments in Medical Diagnostics B.R.A.H.M.S AKTIENGESELLSCHAFT (DE) 2008-10-23 US claimed
EP-1745297-A1 USE OF PRECURSORS OF ENKEPHALINS AND/OR THEIR FRAGMENTS IN MEDICAL DIAGNOSTICS SphingoTec GmbH (DE) 2007-01-24 EP claimed
WO-2005114222-A1 USE OF PRECURSORS OF ENKEPHALINS AND/OR THEIR FRAGMENTS IN MEDICAL DIAGNOSTICS SPHINGO TEC GMBH (DE) 2005-12-01 WO claimed
EP-0937139-A4 AMIDASE DIVERSA CORP (US) 2000-08-02 EP claimed
EP-0937139-A1 AMIDASE DIVERSA CORPORATION (US) 1999-08-25 EP claimed
WO-1997048794-A1 AMIDASE RECOMBINANT BIOCATALYSIS, INC. (US) 1997-12-24 WO claimed
US-20240191260-A1 METHODS OF PREPARING STABLE NUCLEIC ACID LIQUID FORMULATIONS UNIVERSITY OF NORTH CAROLINA AT WILMINGTON (US) 2024-06-13 US disclosed
WO-2024124258-A2 METHODS OF PREPARING STABLE NUCLEIC ACID LIQUID FORMULATIONS UNIVERSITY OF NORTH CAROLINA AT WILMINGTON (US) 2024-06-13 WO disclosed
CN-118005913-A Block copolymer with cell membrane pore-forming property and preparation method and application thereof 四川大学 2024-05-10 CN disclosed
CN-116459240-B Application of KL-2 and derivatives thereof in preparation of antibacterial infection medicines 华中科技大学协和深圳医院 2024-03-19 CN disclosed
CN-116459240-A Application of KL-2 and derivatives thereof in preparation of antibacterial infection medicines 华中科技大学协和深圳医院 2023-07-21 CN disclosed
CN-101214380-A Method and carrier complexes for delivering molecules to cells CORNELL RES FOUNDATION INC (US) 2008-07-09 CN disclosed
CN-1950103-A Method for preventing or treating bone diseases METABOLIC PHARM LTD (AU) 2007-04-18 CN disclosed
EP-1745297-A1 USE OF PRECURSORS OF ENKEPHALINS AND/OR THEIR FRAGMENTS IN MEDICAL DIAGNOSTICS SphingoTec GmbH (DE) 2007-01-24 EP disclosed
WO-2005114222-A1 USE OF PRECURSORS OF ENKEPHALINS AND/OR THEIR FRAGMENTS IN MEDICAL DIAGNOSTICS SPHINGO TEC GMBH (DE) 2005-12-01 WO disclosed
WO-1999058640-A2 MCT-1, A HUMAN ONCOGENE PHILADELPHIA HEALTH AND EDUCATION CORPORATION (US) 1999-11-18 WO disclosed